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ABSTRACT
LMO2 is a bridging factor within a DNA binding com-
plex and is required for definitive haematopoiesis
to occur. The developmental stage of the block
in haematopoietic specification is not known.
We show that Lmo2−/− mouse embryonic stem
cells differentiated to Flk-1+ haemangioblasts, but
less efficiently to haemogenic endothelium, which
only produced primitive haematopoietic progenitors.
Genome-wide approaches indicated that LMO2 is
required at the haemangioblast stage to position
the TAL1/LMO2/LDB1 complex to regulatory ele-
ments that are important for the establishment of
the haematopoietic developmental program. In the
absence of LMO2, the target site recognition of
TAL1 is impaired. The lack of LMO2 resulted in al-
tered gene expression levels already at the haeman-
gioblast stage, with transcription factor genes ac-
counting for ∼15% of affected genes. Comparison
of Lmo2−/− with Tal1−/− Flk-1+ cells further showed
that TAL1 was required to initiate or sustain Lmo2
expression.
INTRODUCTION
LIM only 2 (LMO2) was originally identified through its
homology to LMO1 and was shown to cause T-cell acute
lymphoblastic leukaemia, as a consequence of chromoso-
mal translocations involving LMO2 and the T-cell receptor
genes (1). The protein consists of two LIM domains, which
mediate protein-protein interactions. The first LMO2 pro-
tein complex was characterised in the erythroid lineage and
besides LMO2 contains the transcription factors TAL1,
E2A, LDB1 and GATA1. LMO2 links the DNA bind-
ing TAL1-E2A dimer with GATA1, as well as with LDB1
(2). LDB1 self-associates to form trimeric structures (3),
thereby nucleating multiple LMO2 complexes and facili-
tating long range chromatin interactions (4,5). Further re-
search in erythroid cells identified more components of this
complex and their dynamic changes during differentiation
(6). In addition, other variants of the DNA binding fac-
tors within the LMO2-containing protein complexes have
been reported, where GATA1 is replaced by GATA-2 (7,8),
GATA3 (9) or a second TAL1-E2A dimer (10), as well as
interactions with a number of other transcription factors
(7,11).
Blood development in the mammalian embryo occurs
in three temporally overlapping waves. In the mouse em-
bryo, the first blood cells appear in the extraembryonic yolk
sac around embryonic day (ED) 7.5, consisting of primary
erythroblasts, macrophages and megakaryocytes (12,13). A
day later a second wave starts, also at the yolk sac blood
islands, which produces definitive erythro-myeloid progen-
itors and progenitors with lymphoid potential (14,15). The
yolk sac derived progenitors transiently populate the foetal
liver and circulation, prior to the establishment of the
‘adult’ haematopoiesis (14). The final wave starts at ED10.5
and is characterised by the emergence of the haematopoietic
stem cells (HSCs), which are at the base of the multilineage
haematopoietic hierarchy found in adults. Whereas the first
two waves originate from the yolk sac, the HSCs originate
from the aorta-gonad-mesonephros region of the develop-
ing embryo (16,17). These stem and progenitor cells migrate
to the developing liver, where expansion occurs prior to re-
locating to their final place in the bone marrow (18).
During development, emerging blood progenitors are
the product of a cellular differentiation process, which
starts by the specification of haemangioblasts (HBs). HBs
are mesoderm-derived progenitors that have the poten-
tial to give rise to vascular smooth muscle cells, endothe-
lial cells of the early vasculature and, via a transient
stage of haemogenic endothelium (HE), to haematopoietic
stem and progenitor cells (19–22). HE undergoes a pro-
cess termed endothelial-to-haematopoietic transition, gen-
erating primitive or definitive haematopoietic progenitors
(23,24). LMO2 is crucial for both primitive and definitive
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haematopoiesis (25). Homozygous deletion of Lmo2 leads
to embryonic lethality around ED10.5, due to a complete
lack of yolk sac erythropoiesis (26). However, macrophages
were observed at this stage, indicating that haematopoietic
progenitors were produced, albeit with a block in erythroid
differentiation. Through the analysis of chimeric mice, it
was shown that Lmo2−/− cells did not contribute to defini-
tive haematopoiesis (25). In addition, these cells did not
contribute to the endothelial component of larger blood
vessels, such as the dorsal aorta (27). Chimeras with a high
proportion of Lmo2−/− cells displayed disrupted vascular
organisation. The absence of Lmo2−/− cells from the dor-
sal aorta at the time of the emergence of the HSCs suggests
that they do not participate in the formation of HE at this
site. However, to date the precise nature of this block and
the target genes depending on LMO2 are not known.
The function of the LMO2 binding partners LDB1,
TAL1, GATA1/2 has been studied in knock out mouse
models. Ldb1−/− embryos die between ED8.5 and ED9.5,
Tal1−/− embryos at day 9.5, Gata2−/− embryos die at
ED10.5, whereas Gata1−/− embryos die at ED11.5. The
time of lethality is paralleled with the time of the block
in differentiation. Ldb1−/− mice have blocked vasculoge-
nesis and the number of Flk-1+ HBs is reduced to half of
the level found in WT (28,29). Tal1−/− embryos have de-
veloped vasculature but lack primitive blood islands in the
yolk sack (30). Gata1−/− have developed blood islands that
give rise to primitive macrophages and erythroblasts that
are unable to further mature to erythrocytes (31).Gata2−/−
embryos only have a mild reduction in the number of primi-
tive haematopoietic progenitors and primitive erythrocytes,
but fail to develop definitive haematopoiesis (32). Experi-
ments with chimeric mice showed that TAL1, LMO2 and
GATA2 are instrumental for definitive haematopoiesis and
the formation of all the blood lineages (27,32,33). This is in
line with the finding that in vitro differentiated Tal1−/− ES
cells give rise to Flk-1+ HBs (20), but fail to generate HE
and that GATA2 is required for the specification of the HE
in the dorsal aorta (34).
In this study, we investigate the role of LMO2 dur-
ing early haematopoietic development, using an estab-
lished in vitro differentiation system. In this system, mouse
embryonic stem (ES) cells are differentiated towards the
haematopoietic fate through defined developmental stages
(17,20).We show thatLmo2−/− ES cells can give rise to Flk-
1+ HBs, but have a reduced ability to generate theHE,which
further fails to give rise to definitive haematopoietic pro-
genitors, but inefficiently produces primitive haematopoi-
etic progenitors. Combining genome wide expression, ChIP
and chromatin accessibility assays, we show that in Flk-1+
cells the LMO2 complex regulates many genes encoding
transcription factors and genes important for embryonic
development and differentiation. Changes in gene expres-
sion are already observed at this stage, although upregula-
tion of target genes becomes particularly clear at the follow-
ing HE1 stage. Using Tal1−/− cells we discriminate between
the effects of loss of TAL1 versus LMO2 and identify TAL1
as the initiator of the gene expression program. However, in
Lmo2−/− cells many TAL1 peaks are found at novel posi-
tions, with TAL1 binding only retained at the highest affin-
ity sites found inWT, but at a lower level. This indicates that
LMO2 complex formation is required for correct target site
recognition by TAL1 and for execution of the haematopoi-
etic program.
MATERIALS AND METHODS
Cell culture
The CCB, Lmo2−/− and Tal1−/− ES cell lines and their
culture conditions have been described before (26,35,36).
ES cells were maintained on a layer of primary mouse
embryonic fibroblasts (MEFs) in KnockOut DMEM (Life
Technologies), supplemented with 15% EScult FBS (Stem-
cell technologies), 100 U/ml penicillin, 100 g/ml strep-
tomycin, 25 mM Hepes buffer, 1× Glutamax (Life Tech-
nologies), 1× non-essential amino acids (Sigma), 0.15 mM
monothioglycerol (MTG), 103 U/ml ESGRO (Millipore).
Cells were passaged every other day and tested for my-
coplasma contamination. Prior to the start of differenti-
ation ES cells were passaged in the absence of MEFs on
gelatin-coated dishes and after 24 h the medium was re-
placed with IMDM containing the same additives as for
ES cell maintenance. After 48 h differentiation cultures
were started by diluting single cell suspensions to 3.5 ×
104 cells/ml in in vitro differentiation (IVD) medium, con-
sisting of IMDM, supplemented with 15% heat-inactivated
FBS (Gibco 10500), 100 U/ml penicillin, 100 g/ml strep-
tomycin, 0.15 mM MTG, 50 g/ml ascorbic acid, 180
g/ml human transferrin (Roche). Cell fractionation has
been described before (37,38). Briefly, embryoid bodies
were dissociated with trypsin and Flk-1+ cells were iso-
lated by magnetic cell sorting (MACS) using biotiny-
lated Flk-1 antibody (eBioscience 13-5821), antibiotin mi-
crobeads (Miltenyi Biotec 130-090-485) and MACS LS
columns (Miltenyi Biotec 130-042-401) according to man-
ufacturer’s instructions. For further differentiation of Flk-
1+ cells into haemogenic endothelium and haematopoi-
etic progenitors, cells were cultured in gelatin-coated cul-
ture flasks in IMDM, supplemented with 10% heat inacti-
vated FBS (Gibco 10500), 20% D4T conditioned medium
(24), 100 units/ml penicillin, 100 g/ml streptomycin, 0.45
mM MTG, 25 g/ml ascorbic acid, 180 g/ml human
transferrin (Roche), 5 ng/ml VEGF (PeproTech 450-32), 10
ng/ml IL-6 (PeproTech 216-16). Cell populationswere anal-
ysed using Kit-APC, Tie2-PE, CD41-PECy7 and CD45-
APC antibodies (eBioscience 17-1171, 12-5987, 25-0411,
17-0451) by FACS (BDFACSAria Fusion) and flow cytom-
etry (Beckman Coulter CyAn ADP).
Expression analysis
RNA was isolated using an RNeasy Mini Kit (QIAGEN)
according to the manufacturer’s protocol, after which con-
centration and quality were determined on a NanoDrop
2000 UV-Vis Spectrophotometer (Thermo Scientific). For
cDNA synthesis, typically 2 g RNA was reverse tran-
scribed using Oligo(dT)12–18 primer and SuperScript II Re-
verse Transcriptase (Life Technologies), after which gene
expression was measured by quantitative PCR (qPCR), us-
ing SYBR green (Thermo Fisher 4309155) on an ABI 7500
Real-Time PCR System with primers listed in Supplemen-
tary Table S1. Quantitation was carried out using a stan-
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dard curve generated by a five-point 4-fold serial dilution of
cDNA. RNAseq libraries were prepared using the TruSeq
Stranded mRNA Sample Preparation Kit (Illumina), using
1 g total RNA per sample. Three independent libraries
were prepared of Flk-1+ and two of HE1. Libraries were
run on an Illumina HiSeq 2500 sequencer. At least 30 mil-
lion 100nt paired-end reads were acquired per library.
Western blotting
Crude nuclear extracts were prepared as described be-
fore (39) and separated on 4–12% gels (Novex, Life Tech-
nologies). Proteins were transferred to nitrocellulose mem-
branes, blocked and incubated overnight with primary an-
tibody, followed by 1 h incubation with the appropriate sec-
ondary antibody. Primary antibodies raised against TAL1
(Santa Cruz sc-12984X), Ldb1 (Abcam ab96799), LMO2
(R&D systems AF2726), -actin (Sigma A1978) were used
at a final concentration of 1 g/ml and secondary anti-
bodies were IRDye 680RD or 800RD (Li-Cor), which were
used at a 1:2000 dilution. Fluorescence was detectedwith an
Odyssey CLx Imager (Li-Cor). Quantitation of bands was
performed by densitometry, using the Odyssey v3.0 soft-
ware.
DHS mapping
GenomewideDNaseI hypersensitivity (DHS)mappingwas
performed as described before (39,40). DNA from in vivo
DNase1-treated cells was isolated and approximately 10 g
was size fractionated on an agarose gel. DNA fragments
in the range of 100–600 bp were isolated using QIAGEN
gel purification columns and library preparation was per-
formed according to the Illumina library preparation pro-
tocol. Sequencing was performed on an Illumina Genome
Analyser.
Chromatin immunoprecipitation
Chromatin Immunoprecipitation (ChIP) assays were per-
formed as described (38). Isolated Flk-1+ cells were
crosslinked with 1% formaldehyde for twelve minutes at
room temperature. Nuclei were isolated and the chromatin
was sonicated for 10 cycles of 30 s on 30 s off at 4◦C, us-
ing a Q800R sonicator (Active Motif). Immunoprecipita-
tion was carried out using protein G magnetic beads (Dy-
nal) with the antibodies as described for western blotting
(1.5 g antibody/10l of beads). After elution, crosslinks
were reversed overnight at 65◦C, after which the DNA was
isolated using Ampure PCR purification beads and anal-
ysed by qPCR (for primers see Supplementary Table S1)
or libraries were prepared using the Illumina protocol with
indexed primers. Libraries were run on an Illumina HiSeq
2500 in rapid run mode.
Genome wide data analysis
Global analysis of the genome wide data was performed on
usegalaxy.org (41–43) and on theUniversity of Birmingham
High Performance Computing cluster.
Acquired RNAseq reads were mapped to the mouse
genome (GRCm38/mm10) using TopHat 2.0.9 (44). Tran-
scripts were assembled using Cufflinks 2.0.0 based on the
reference genome with quartile normalisation and effective
length correction. A combined gtf file was produced using
Cuffmerge 2.1.1 and used for determination of the differen-
tial gene expression using Cuffdiff 2.0.1. Principle compo-
nent analysis and hierarchical clustering were performed on
all RNAseq samples to assess inter-sample variation (Sup-
plementary Figure S3C and S3D). Gene differential expres-
sion and FPKM gene expression files were used to select
the gene IDs that were significantly differentially expressed,
with P < 0.05, longer than 200 bp and FPKM >10 in at
least one of the samples.Heatmaps,Hierarchical Clustering
were computed byMultiExperiment Viewer v4.9.0 based on
Pearson correlation with complete linkage. The number of
clusters was determined by Self Organizing Tree Analyses.
Gene ontology enrichment was performed using DAVID
6.7 (45) and GREAT (46). GO terms for biological pro-
cesses with P-value <0.05 were considered significant, cat-
egories with redundant terms were filtered out, and the first
10 were presented.
For DHS and ChIPseq analysis, reads were mapped to
the mouse genome mm10 (GRCm38) using Bowtie 1.1.2.
Duplicates were removed using Picard MarkDuplicates
1.56.0 and peaks were called using MACS 1.0.1 (47) with
tag size 28 and band width 200. For LMO2 WT and KO
DHS unions, LMO2 WT and KO DHS summits were con-
catenated (48). DHS tag counts (±1000 bp) around the
summits were retrieved usingHomer (49). Tag counts (±100
bp) of each summit were added up, log2 transformed and
sorted by increasing log2 LMO2 KO/WT fold change. For
the LMO2 ChIP and corresponding heatmaps, WT LMO2
ChIP summits were sorted by descending tag counts and
tag counts (±1000 bp) around summits were recovered.
Heatmaps were generated with Java TreeView (50).
Genome wide data reported in this study are available
from the NCBI Gene Expression Omnibus portal (GEO:
GSE99938).
RESULTS
Lmo2−/− cells are progressively compromised in their
haematopoietic potential
Lmo2−/− cells do not contribute to the definitive
haematopoietic system (25,27). In order to determine
at which stages the developmental block occurs, we em-
ployed an established in vitro ES cell differentiation system
(Figure 1A) (20), usingWT and Lmo2−/− ES cell lines (26).
ES cells start differentiation by generating embryoid bodies
(EBs). From these, haemangioblasts were enriched by
isolating Flk-1+ (VEGFR2) cells, which were subsequently
either used for analysis, or further cultured in blast medium
for the formation of haemogenic endothelium 1 (HE1;
Tie2+, Kit+, CD41−), and via haemogenic endothelium 2
(HE2; Tie2+, Kit+, CD41+) to haematopoietic progenitors
(Tie2−, Kit+/−, CD41+). Expression of Lmo2 was first
detected in the early Flk-1+ cells, isolated at day 3.0 and
was increased in Flk-1+ cells isolated at day 3.75. This level
was maintained in HE1 and haematopoietic progenitor
cells (Figure 1B). Differentiation of WT and Lmo2−/− ES
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Figure 1. LMO2 is necessary for haematopoietic development. (A) Schematic representation of the ES cell in vitro differentiation system. ES cells were
differentiated and Flk-1+ cells were isolated from embryoid bodies. These were then further differentiated in a blast culture, giving rise to haemogenic
endothelial cells (HE1 followed by HE2), which subsequently generate haematopoietic progenitor cells. (B) Expression levels of Lmo2 mRNA during
in vitro ES cell differentiation, measured by qPCR. Data are the mean of at least three independent samples measured in duplicate ± SEM and were
normalised to Hprt expression. (C) WT and Lmo2−/− ES cells were differentiated to day 3.75. Flk-1 surface expression was measured by flow cytometry,
with prior gating for live cells using the FSC and SSC plot. (D) WT and Lmo2−/− cells were harvested at day 2 of the blast culture and stained for Kit,
Tie2, and CD41 surface expression. Indicated percentages relate to the total number of gated live cells, using the FSC and SSC plot. (E) Abundance of
Flk-1+, HE1, HE2, and progenitors in Lmo2−/− differentiation cultures, relative to WT. Data are the mean of at least three independent samples ± SEM.
(F) WT and Lmo2−/− progenitor cells were enriched at day 3 of blast culture by resuspending non- and loosely-adherent cells and stained for CD41 and
CD45 surface expression. Representative scatter plots are shown.
cells into day 3.75 EBs showed that Lmo2−/− cells had
equal capacity to generate Flk-1+ cells (Figure 1C and
E). Further differentiation of haemangioblasts in blast
medium, resulted in the generation of Tie2+, Kit+ HE.
However, cultures of Lmo2−/− cells typically contained
only 40% of the HE cells observed in the WT and the
number of haematopoietic progenitors was further reduced
to approximately 20% of WT (Figure 1D and E). Staining
of haematopoietic progenitors for CD41 and CD45 at day
3 of the blast culture showed an almost complete absence
of CD45+ Lmo2−/− progenitors, indicating that these
progenitors are a product of primitive haematopoiesis
(Figure 1F). The expression profile of key transcription
factors genes showed the WT CD41+, CD45− progenitors
expressed higher levels of Tal1, Gata1, Gata2, Runx1, Gfi1,
Gfi1b, and Nfe2, whereas CD41+, CD45+ cells exhibited
higher levels of Spi1 and Cebpb (Supplementary Figure
S1).
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RNAseq analysis reveals affected transcriptional regulators
To investigate how the lack of LMO2 impacts on gene
expression, we analysed purified WT and Lmo2−/− Flk-
1+ cells and HE1 by RNAseq (Figure 2A, Supplemen-
tary Figures S2 and S3). Pairwise comparisons identified
2593 differentially expressed genes (Figure 2B). Differen-
tiation from HB to HE1 was characterised by a progres-
sive deviation of gene expression between wild-type and
Lmo2−/− cells accounting for 69% (1777 genes) of the dif-
ferential gene expression. At the haemangioblast stage only
143 genes were differentially expressed between WT and
Lmo2−/−. Hierarchical clustering of these genes revealed
that the expression of these genes is specific to the HB
stage since the majority of the genes are not expressed
in the HE1 cells (Figure 2C). Subsequent gene ontology
analysis showed that Lmo2−/− cells failed to upregulate
genes important for endoderm formation, cell fate com-
mitment and haematopoietic development amongst oth-
ers, whereas genes involved in heart and muscle develop-
ment and endothelial fate were expressed at higher levels
by Lmo2−/− cells (Figure 2D). Transcriptional regulators
were well represented in both clusters. Within the list of
transcriptional regulators down-regulated in Lmo2−/− Flk-
1+ cells we found several transcription factors with known
functions at the HB / HE1 stages. These included the en-
domesodermal T-box factors T and Eomes, and transcrip-
tion factors important for haematopoietic development,
such as Tal1, Erg, Gata2 and Fli-1 (Supplementary Fig-
ure S3A). Self-organizing tree clustering of all the differ-
entially expressed genes produced six clusters (Figure 2E).
Two clusters typified by higher expression in the WT cells
are cluster 5 (highWT Flk-1+ and HE1) and cluster 6 (high
WT HE1), whereas cluster 2 showed elevated expression in
Lmo2−/− HE1. These three clusters were subjected to gene
ontology analysis (Figure 2F). Cluster 5 is heavily domi-
nated by terms involving translation, RNA processing and
RNA metabolism, whereas cluster 6 showed cellular pro-
cesses and angiogenesis. Cluster 2 on the other hand indi-
cated alternative cell fates, such as epithelium, endothelium,
muscle development and limb formation.
Positive feedback between LMO2 and TAL1 regulates their
expression levels
OurRNAseq data indicated thatTal1mRNA levels were re-
duced inLmo2−/− Flk-1+ cells, but not inHE1 (FPKM32.5
versus 13.5 inWTandLmo2−/− HBrespectively). Although
qPCRdid not detect a significant change inTal1mRNA ex-
pression, we observed a reduction in TAL1 protein of>75%
in Lmo2−/− Flk-1+ cells (Figure 3A and B), whereas the
abundance of other components of the complex were unaf-
fected (Figure 3B, Supplementary Figure S4). This finding
could infer that most of the Lmo2−/− phenotype was due
to the reduction in TAL1 protein. To address this we dif-
ferentiated Tal1−/− ES cells. Interestingly, RNAseq analy-
sis of Lmo2 expression in Tal−/− Flk-1+ cells showed that
mRNA was at background levels and LMO2 protein was
not detectable, highlighting the importance of TAL1 for
Lmo2 gene activation (Figure 3A and B). The data therefore
showed thatTal1−/− HBs were not only deficient for TAL1,
but also for LMO2, whereas the Lmo2−/− cells retained
low levels of TAL1 protein. RNAseq on the Tal1−/− Flk-1+
cells and the comparison with theWT andLmo2−/− cells at
this stage identified 826 differentially expressed genes (Fig-
ure 3C). Hierarchical clustering of these genes indicated
that Tal1−/− HBs are more divergent from the WT than
Lmo2−/− HBs (Figure 3D).Gene ontology analysis on clus-
ter 5, which contains genes that are expressed at the highest
level in Tal1−/− cells (Figure 3E), showed a large number of
transcriptional regulators. In addition, it showed upregula-
tion of early developmental processes and alternative cell
fates, such as epithelium, skeletal, keratinocyte and gland
development. This indicates that theTal1−/− HBs displayed
a developmentally earlier defect thanLmo2−/− HBs, as they
failed to suppress the somatic mesoderm and neural crest
gene expression program.
Lmo2 deficiency leads to the selective loss of accessible chro-
matin sites
In order to understand how the accessibility of cis-
regulatory elements, such as promoters and enhancers, was
influenced by the absence of LMO2 we performed DNaseI
hypersensitive site (DHS) mapping on WT and Lmo2−/−
Flk-1+ cells. Cells were purified and subjected to in vivo
DNaseI digestion, after which DNA fragments were iso-
lated and processed for sequencing. We identified 40 989
DHSs in the WT cells and 41 963 DHSs in Lmo2−/− cells.
The intersection of these two datasets showed that the ma-
jority of theDHSs overlap (Figure 4A). However, the analy-
sis also showed that a large number of DHS present in WT
cells was lost in Lmo2−/− cells. De novo motif analysis of
this population of DHSs (Figure 4B) showed a strong en-
richment for class I bHLHE-box (e.g. E2A), class II bHLH
E-box (e.g. TAL1) and GATAmotifs, which are all compo-
nents of the LMO2 complex. The Lmo2−/−-specific DHSs
on the other hand were enriched in LEF/TCF motifs. We
next ranked the ratio of tag counts in the DHS between
WT and Lmo2−/− samples and plotted the position of the
enriched motifs in relation to the DHS (Figure 4C). All
motifs were localized in the centre of the DHSs thus val-
idating the approach. The distribution of motifs between
specific and shared DHS revealed that TAL1 E-box motifs
and GATA motifs were enriched in the WT-specific DHSs,
in particular as bipartite motifs of either TAL1-GATA or
TAL1-TAL1, the latter originally described in vitro by the
Rabbitts lab (2,10). SP1, ETS, and CREB motifs were en-
riched in the shared DHSs and T-box motifs were found
throughout. These finding were confirmed by performing
bootstrapping analysis on the top 10% of the DHSs ranked
by WT/Lmo2−/− ratio, showing co-localisation of motifs
for E2A, TAL1 andGATA in this DHS subset (Supplemen-
tary Figure S5).
ChIPseq analysis shows a limited number of strong binding
sites for the LMO2 complex
To examine, whether the loss of DHSs in Lmo2−/− HBs
was due to the loss of the LMO2 complex, we determined
the LMO2 targets in WT Flk-1+ cells by ChIPseq analy-
sis (Figure 5A, Supplementary Figure S6A). Using anti-
bodies recognising LMO2, TAL1 and LDB1 we detected
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Figure 2. RNAseq analyses of WT and Lmo2−/− Flk-1+ and HE1 cells. (A) Screenshots from the UCSC browser illustrating the distribution of reads over
the Eomes; Ets2, and Erg loci. Uniform y-axis scales were used for each genomic region and positive and negative values correspond to the direction of the
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6578, 4043 and 2280 peaks, respectively. The intersection
of the data sets showed that the three-way overlap was re-
stricted to 486 peaks (Figure 5B). Motif analysis of these
high confidence LMO2-complex binding sites revealed that
the GATAmotif was the most significantly overrepresented
(Figure 5C). In addition we found several other associated
motifs, such as ETS andE-boxmotifs. Ranking theChIP re-
sults according to the DHSs fold change as shown in Figure
4, it was clear that the strongest ChIP signal occurs at the
top for each of the ChIPseq samples and that the three-way
overlap was highly enriched for WT specific DHSs (Figure
5D). One example of a target element where all three fac-
tors bind together, and where the DHS is severely affected
in Lmo2−/− Flk-1+ cells, is the enhancer of the Lmo1 gene
(Figure 5A) (51). Taken together, our analyses show that (i)
the loss of LMO2 leads to a loss of specific cis-regulatory el-
ements, and (ii) that those elements are characterized by the
presence of co-localizing motifs that bind known members
of the LMO2 complex.
In order to find genes that TAL1 regulates in the ab-
sence of LMO2, we combined the Lmo2−/− and Tal1−/−
gene expression data shown in Figure 3 with the TAL1
ChIPseq data. We identified the nearest genes of the TAL1
peaks with significantly different gene expression between
the Lmo2−/− and Tal1−/− Flk-1+ cells, which resulted in
a list of 135 genes. The majority of these genes (85%) had
higher expression in the Tal1−/− cells implying that TAL1
acts as a suppressor in the absence of LMO2 (Figure 5E).
Gene ontology analyses of biological processes revealed
that among TAL1 targets many are transcription factors
and suppressors of the canonicalWnt pathway (Figure 5F).
TAL1 and LDB1 binding is redistributed in the absence of
LMO2
We next investigated the localisation of LMO2, TAL1 and
LDB1 in the absence of LMO2 by performing ChIPseq in
Lmo2−/− Flk-1+ cells and compared these data to the WT-
derived data sets (Figure 6A). The LMO2ChIP inLmo2−/−
Flk-1+ cells resulted in a track without peaks, whereas 3127
peaks were called in Lmo2−/− samples using the TAL1 an-
tibody and 2200 peaks for the LDB1 antibody (Figure 6B).
We first ranked the ChIPseq peaks according to the WT
LMO2 ChIP signal (Figure 6C) and compared the signals
to the corresponding TAL1 and LDB1 peaks. This compar-
ison demonstrated that the strongestWTLMO2peaks were
mirrored by the strongest TAL1 and LDB1 peaks. When
looking at less strong LMO2 peaks, there was less overlap.
However, these sites do show accumulation of reads in the
TAL1 and LDB1 ChIP (lower part of Figure 6C), albeit not
sufficiently to be recognised as peaks by data analysis. The
LMO2 binding sites were enriched for the same motifs as
shown for theWT-specific DHSs, i.e. TAL1, GATA, TAL1-
GATA, TAL1-TAL1, as well as for ETSmotifs (Figure 6D),
whereas transcription factor bindingmotifs that were found
enriched at non WT-specific DHSs were not enriched at
the LMO2 peaks (Supplementary Figure S6B). Compari-
son of theWTChIP data with those from theLmo2−/− Flk-
1+ cells showed that TAL1 and LDB1 binding was largely
lost, with significant levels only being left at those bind-
ing sites where LMO2 occupancy was the strongest in WT
(Figure 6C). GATA2 ChIP experiments indicated that also
GATA2 bindingwas reduced in the absence of LMO2, how-
ever, the DNA pulldown we achieved was insufficient for
genome wide analysis (Supplementary Figure S6A). The
LMO2 peak present on the first exon of the Lyl1 gene was
one of the strongest in WT cells and serves as a good exam-
ple of a position where TAL1 and LDB1 binding is clearly
observed in the absence of LMO2 (Figure 6A). Peaks at the
Gata1 and Nfe2 genes are representative of the majority of
binding sites, which show very little or absent residual bind-
ing without LMO2 (Supplementary Figure S6C). Approx-
imately half of the peaks within each of the ChIPseq data
sets fall within intragenic and promoter regions (Figure 6E)
in line with the chromatin nucleating function of LDB1,
bringing distant regulatory elements in the vicinity of the
gene they are regulating (3,4).
We observed that TAL1 and LDB1 binding in the
Lmo2−/− HBs was extensively redistributed to new sites
(Figure 6B). As LDB1 has multiple other potential bind-
ing partners in these cells, such as LMO4, LHX, OTX pro-
teins (6,10,52), its changed distribution in the absence of
LMO2 could be anticipated. In contrast, the redistribution
of TAL1 binding in the Lmo2−/− was more surprising as
it has been shown that TAL1 is capable of binding DNA in
the absence of LMO2 (2,53). In order to further analyse this,
we ranked the TAL1ChIPs ofWT andLmo2−/− cells based
on their signal ratio (Supplementary Figure S7A), which in-
deed showed a clear population of TAL1 peaks exclusive
for Lmo2−/− cells. The average TAL1 ChIP signal distri-
bution showed that TAL1 peaks in the Lmo2−/− cells have
a lower intensity than in WT cells (Supplementary Figure
S7B). Additionally, TAL1 peaks specific to the Lmo2−/−
cells did not overlap with the WT LMO2 ChIP signal, or
increased accessibility of the chromatin. Analysis of the E-
box and GATA motif distribution indicated a striking re-
duction of E-box motifs and absence of GATA motifs at
these sites (Supplementary Figure S7A). Our results suggest
that the TAL1/LMO2 interaction is essential for the cor-
rect TAL1 DNA binding and thereby for the positioning of
TAL1/LMO2/LDB1 complex. Experiments where LMO2
deficiency was corrected by an inducible LMO2 transgene
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
transcripts. The screenshots are flanked by gene expression levels of Eomes and Erg, measured by qPCR. Data represent the mean of three independent
samples measured in duplicate ± SEM relative to Hprt. (B) Pairwise comparison of the significantly differentially expressed genes. Shown are the total
number of up or down regulated genes for each comparison and their overlap. Quantitation and analyses of RNAseq data are based on biological triplicate
samples for Flk-1+ cells and duplicates for HE1 cells. (C) Heat map showing hierarchical clustering of differentially expressed genes at the Flk-1+ stage.
(D) Gene ontology enrichment analyses for biological process performed on the two clusters identified in C. (E) Heat map showing hierarchical clustering
of all differentially expressed genes. Scale bar represents colour index for the log2 FPKM values. Self-organizing tree analysis identified six clusters, which
are numbered 1 to 6. (F) Gene ontology enrichment analyses for biological process was performed on clusters 2, 5, 6 identified in E. Terms were ordered
according to their Modified Fisher Extract P-value and only terms with P<0.05 were considered significant.
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Figure 3. Gene expression analysis of Tal1−/− Flk-1+ cells. (A) Lmo2, Tal1 gene expression relative toHprt in Flk-1+ cells derived fromWT, Lmo2−/− or
Tal1−/− ES cells. Data represent the mean of three independent samples measured in duplicate± standard deviation. (B) LMO2, TAL1, LDB1 and -actin
protein levels detected by western blotting using nuclear extract from WT, Lmo2−/− and Tal1−/− Flk-1+ cells. (C) Pairwise comparison of significantly
differentially expressed genes. Quantitation and analyses of RNAseq data are based on biological triplicate samples. (D) Heat map showing hierarchical
clustering of differentially expressed genes at the Flk-1+ stage. (E) Gene ontology enrichment analysis for biological process was performed on cluster 5 as
identified in D. Terms were ordered according to their Modified Fisher Extract P-value and only terms with P < 0.05 were considered significant.
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Figure 4. Analysis of DNaseI chromatin accessibility. (A) Venn diagram comparing DNaseI hypersensitive sites of WT and Lmo2−/− Flk-1+ cells. (B)
De novomotif analysis showing enriched motifs within the WT-specific and Lmo2−/−-specific DHSs, their DNA-binding factors and associated P-values.
(C) Heat maps showing DHSs ranked according to their WT/Lmo2−/− ratio showing a window from –1 kb to +1 kb around the centre of the DHSs.
The left two panels show the DHSs from the WT and Lmo2−/− Flk-1+ cells. Beside it a guide indicates which positions show a WT/Lmo2−/− ratio of
>log2 (green; 6921 sites), Lmo2−/−/WT ratio of >log2 (red; 5050), or a ratio of <log2 (black; 35 964). The panels to the right show the presence of the
indicated motifs, using the same ranking and window from –1 kb to +1 kb around the centre of the DHSs. Below each binding motif matrix an average
profile represents the distribution of the WT-enriched (green), common (black) and Lmo2−/−-enriched (red) motifs.
showed a clear rescue of both LMO2 and TAL1 binding at
target sites (Supplementary Figure S8).
Strong LMO2 binding sites correspond to differentially ex-
pressed genes
We next correlated ChIPseq binding data with differ-
ential gene expression. To this end, we determined the
WT/Lmo2−/− ratio of gene expression of the nearest genes
to the LMO2/TAL1/LDB1 triple peaks, in HBs and HE1
and ranked them according to the WT LMO2 peak sig-
nal intensity (Figure 7A). There was a clear positive cor-
relation between the top triple peaks and the gene expres-
sion of the nearest genes in HBs, indicating that these genes
were particularly sensitive to the absence of the LMO2 com-
plex. Less strong peaks correlated less often with changes
in gene expression. In comparison, the correlation between
the HB triple peaks and the gene expression at the HE1
stage showed a much more extensive effect on gene expres-
sion, which was along all the peaks and correlated with
both up and down regulation (Supplementary Figure S9).
Gene ontology analysis of biological processes for these ge-
nomic coordinates revealed almost exclusively haematopoi-
etic processes (Figure 7B). The total number of genes that
were determined to be significantly upregulated or down-
regulated is shown in Figure 7C. Hierarchical clustering
of these gene expression levels, including the gene expres-
sion from Tal1−/− HBs, resulted in three clusters (Figure
7D). Cluster 3 contained genes that failed to upregulate in
Lmo2−/− HE1. This cluster contained a large number of
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Figure 5. Binding profiles of LMO2, TAL1 and LDB1 in Flk-1+ cells. (A) Screenshot from the UCSC browser showing LMO2, TAL1 and LDB1 binding
profiles, DNaseI accessibility inWT andLmo2−/− Flk-1+ cells, andRNAseq ofWT andLmo2−/− Flk-1+ andHE1 cells at theLmo1 locus. Uniform y-axis
scales were used for all RNAseq tracks and for the DNaseI WT to Lmo2−/− pairwise comparison. (B) Three-way Venn diagram showing the intersection
of LMO2, TAL1 and LDB1 ChIPseq data obtained from Flk-1+ cells. (C) De novo motif analysis showing enriched motifs within the 486 peaks that are
common for all three transcription factors. (D) Ranking of the ChIPseq data according to the WT/Lmo2−/− ratio as described in Figure 4 showing read
density in a window from –1 kb to +1 kb around the centre of the DHSs, flanked by a density plot indicating the positions of three-way overlaps. (E) Log2
FPKM expression data of significantly differentially expressed genes between Lmo2−/– and Tal1−/− Flk-1+ cells, associated with TAL1 ChIPseq peaks.
Genes were ranked according to their FPKM fold change. (F) Gene ontology enrichment analysis for biological process was performed on the 135 genes
as identified in E. Terms were ordered according to their Modified Fisher Extract P-value, only terms with P < 0.05 were considered significant, and the
top 10 are shown.
genes encoding transcription factors with known involve-
ment in haematopoietic development, such as Rxra, Stat3,
Stat5b, Ebf1, Nfatc1, Gata2, Sox7, Runx1t1 (ETO) and
Pbx1. The lack of LMO2 and absence of haematopoietic
differentiation therefore correlates with the absence of a
haematopoiesis-specific transcriptional program.
DISCUSSION
Lmo2 is one of few transcriptional regulators which are
part of the very core of blood stem/progenitor cell iden-
tity. LMO2 is essential for both primitive erythropoiesis
and definitive haematopoiesis (25,26). Moreover, LMO2 is
required for reprogramming of committed blood cells to
induced haematopoietic stem cells (54). Failure to repress
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Figure 6. LMO2, TAL1 and LDB1 binding profiles in WT and Lmo2−/− haemangioblasts. (A) Screenshot from the UCSC browser showing LMO2,
TAL1 and LDB1 binding profiles and DNaseI accessibility in WT and Lmo2−/− Flk-1+ cells, and RNAseq of WT and Lmo2−/− Flk-1+ and HE1 cells
at the Lyl1 locus. Uniform y-axis scales were used for all RNAseq tracks and for each WT to Lmo2−/− pairwise comparison. (B) Venn diagrams showing
the overlap of the TAL1 and LDB1 ChIPseq peaks obtained from WT or Lmo2−/− Flk-1+ cells. (C) ChIPseq data for LMO2, TAL1 and LDB1 in WT
and Lmo2−/− Flk-1+ cells, ranked according to the WT LMO2 ChIP signal, showing read density in a window from –1 kb to +1 kb around the centre of
the LMO2 peaks. Below each matrix an average profile shows the distribution of the ChIP signal throughout the matrix. (D) Motif distribution matrices
ranked according to the WT LMO2 ChIP signal, with average distribution profiles below. (E) Fractionation of peaks of each of the ChIPseq datasets on
basis of their position in relation to genes.
Lmo2/Tal1 or reinstatement of their expression in lineage-
committed cells induces stem cell properties (55,56). Re-
cently, we showed that LMO2, in combination with TAL1,
was at the start of the generation of a dynamic gene regu-
latory network programming haematopoietic specification,
using in vitro ES cell differentiation (37). With the same dif-
ferentiation system, we now used Lmo2 and Tal1 knockout
cell lines to gain further understanding of the precise role
of LMO2 at these initial stages of haematopoietic devel-
opment. We found that Lmo2 expression was established
during the development of HBs and that the generation
of Lmo2−/− Flk-1+ cells was not affected. However, the
progression from HB to HE occurred with reduced effi-
ciency and Lmo2−/− HE could only give rise to a small
number of primitive haematopoietic progenitors. Therefore,
Lmo2−/− cells were not blocked at one developmental stage
of haematopoietic specification, but had a progressive de-
fect. These observations are in agreement with the pheno-
type observed in mice.
Although WT and Lmo2−/− ES cells have a similar ca-
pacity to produce Flk-1+ cells, our experiments showed that
LMO2 exerts its function already at the HB stage by po-
sitioning the LMO2 complex to regulatory elements im-
portant for the establishment of the haematopoietic pro-
gram. As the peaks identified by the three-way overlap of
the LMO2, TAL1 and LDB1 ChIPseq data were the sites
with the highest number of reads in each of the indepen-
dent samples, we conclude that these regulatory elements
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Figure 7. High-affinity LMO2 binding sites in the WT hemangioblasts are in the vicinity of genes that are upregulated in WT HE. (A) Heatmap of the
FPKM fold change between the WT and Lmo2−/− for the genes nearest to the LMO2 ChIPseq peaks, at the Flk-1+ (left) and HE1 (right) stages. FPKM
ratios are ranked according to the WT LMO2 ChIPseq signal. Scale bar represents colour index for the FPKM fold change. (B) GREAT gene ontology
enrichment analysis for biological process performed on genomic regions of the triple peaks. (C) Table showing the number of genes associated with LMO2
ChIPseq peaks that have increased or decreased expression (>4-fold) in WT compared to Lmo2−/− cells. (D) Heat map of hierarchically clustered genes
that associate with common TAL1, LMO2 and LDB1 ChIPseq peaks. These genes are either the nearest 5′ or 3′ gene, or contain the peak within the gene
body. Scale bar represents colour index for the log2 FPKM values. Self-organizing tree analysis identified three clusters, which are numbered 1 to 3.
exhibit the highest affinity for this complex. In the absence
of LMO2, binding of TAL1 only remained at the strongest
of these binding sites, albeit at a lower level, whereas thema-
jority of TAL1 binding was found at novel binding sites. It
has previously been shown that the interaction of LMO2
with TAL1 directly increases the stability of TAL1/E2A
heterodimer (57). Experiments with TAL1 DNA-binding
deficient mutants showed that DNA-binding activity of
TAL1 was dispensable for specification of haematopoietic
development (53), only when the interaction of the TAL1
HLH domain with LMO2 was retained (57). In addition,
in the presence of LMO2, TAL1 could associate with chro-
matin in the absence of its DNA binding domain, albeit
with a lower affinity (58). Our motif analysis of the three-
way overlap of LMO2, TAL1 and LDB1 ChIP indicated a
very strong enrichment of GATA bindingmotifs (Figure 5).
Taken together, this indicates that the interaction through
LMO2plays an important role in directing TAL1 to the cor-
rect binding sites, whereas without LMO2, TAL1 has lower
DNA binding activity and specificity. Comparison of our
data to previously published LDB-1 ChIPseq data in Flk-
1+ cells (28) and in Lin− bone marrow (59) showed that the
overlap is particularly enriched for those LDB1 peaks that
are part of the three-way overlap (83% and 51% of LMO2,
TAL1 and LDB1ChIP peaks respectively). In addition, our
and previous studies identify the same list of target genes
(e.g. Tal1, Gata2, Runx1, Lmo2, Runx2t2 and Sox7). Inter-
secting the lists of differentially expressed genes reported by
Mylona et al. indicated that the Ldb1−/− was more similar
to the Tal1−/−, in line with the developmental block occur-
ring earlier than in the Lmo2−/−.
Meta-analysis of the LMO2 complex binding sites iden-
tified an overrepresentation of regulatory elements impor-
tant for haematopoietic development. These included tran-
scription factor genes known to be important at the HB
stage (e.g. Fli1 (52,59), Gata2 (32), Erg (55)), genes that
are important for the HE and endothelial-haematopoietic
transition (e.g. Gfi1 (60)), those with known haematopoi-
etic stem cell function (e.g. Lyl1 (61), Stat3 (62)), and tran-
scription factors with more lineage restricted functions (e.g.
Ebf1 (63), Gata1 (64), Nfe2 (65)). Our findings indicate
that already at the HB stage, LMO2 primes transcription
factor genes which will be upregulated at later stages of
haematopoiesis and thus regulates all steps of haematopoi-
etic development.
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TAL1 and LMO2 are clearly intimately linked in their
function and their knock-out phenotypes are similar. In
vitro differentiation of Lmo2−/− cells demonstrated less se-
vere differentiation defects than observed in Tal1−/-(20).
Lmo2−/− Flk-1+ cells showed reduced Tal1 mRNA and
protein levels, whereas inTal1−/− Flk-1+ cellsLmo2mRNA
was completely lost, indicating that TAL1 is required for the
initiation of Lmo2 expression. This is in contrast to stud-
ies in zebrafish, which showed that the absence of TAL1 or
LMO2 did not influence the mRNA expression of the other
(66,67), although injection of Tal1 mRNA in zebrafish em-
bryos could induce Lmo2 expression in somitic paraxial
mesoderm (68).The residual DNA binding by remaining
TAL1 protein is likely the reason why a fraction of Lmo2−/-
cells differentiate fromHB toHE1 and give rise to primitive
haematopoietic progenitors. The comparison of Lmo2−/−
toWTHEmay serve to define the differences between prim-
itive and definitiveHE of themouse. Also, it was shown that
Tal1−/− cells do not upregulate Runx1 expression and that
the differentiation defect could be partially rescued by intro-
duction of RUNX1 (69). In contrast, Lmo2−/− HE1 does
express Runx1, indicating that its upregulation is not ad-
versely affected by the absence of LMO2. As RUNX1 is vi-
tally important for the HE identity and the transition from
HE to haematopoietic progenitors (38), this could represent
a crucial difference between Lmo2−/− and Tal1−/− cells.
The in vitro differentiation of ES cells to the haematopoi-
etic fate with particular transcription factors knocked out,
has served as a great tool to further our understanding
of how transcriptional networks operate throughout differ-
entiation programs (20,28,36,38,60,69,70). Several of these
studies have used induced expression of transcription fac-
tors to understand their capacity to rescue the observed
knock-out phenotype. Given that the Lmo2−/− phenotype
is progressive through differentiation and that this seems re-
flected in the developmental spread of the affected target
genes, multiple target genes may need to be induced before
haematopoietic development is efficiently restored.
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